Publication | Closed Access

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

NeonatologyPediatric HydrocephalusHypoxic Ischaemic EncephalopathyPediatricsNeuropharmacologyFeasibility Phase 1/2Dose FindingNeurologyNeuropathologyMedicine